Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 89621 - 89640 out of 495984 entries
Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
---|---|---|---|---|---|---|---|---|
Canada | (B03XA01) erythropoietin (adm: P) | Eprex | Liq/Liq. Inj 5 000 IU / 0.5 mL,Syringe / seringue | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | JAN |
Canada | (B03XA01) erythropoietin (adm: P) | Eprex | Liq/Liq. Inj 6 000 IU / 0.6 mL,Syringe / seringue | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | JAN |
Canada | (B03XA01) erythropoietin (adm: P) | Eprex | Liq/Liq. Inj 8 000 IU / 0.8 mL,Syringe / seringue | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | JAN |
Canada | (B03XA01) erythropoietin (adm: P) | Eprex | Liq/Liq. Inj 10 000 IU/mL,Syringe / seringue | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | JAN |
Canada | (B03XA01) erythropoietin (adm: P) | Eprex | Liq/Liq. Inj 20 000 IU / 0.5 mL,Syringe / seringue | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | JAN |
Canada | (B03XA01) erythropoietin (adm: P) | Eprex | Liq/Liq. Inj 30 000 IU / 0.75 mL,Syringe / seringue | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | JAN |
Canada | (B03XA01) erythropoietin (adm: P) | Eprex | Liq/Liq. Inj 40 000 IU/mL,Syringe / seringue | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | JAN |
Canada | (B03XA02) darbepoetin alfa (adm: P) | Aranesp | Liq/Liq. Inj 10 mcg / 0.4 mL,Syringe / seringue | Ex-factory price without vat |
$0-0 |
$0-0 |
Anemia;Cancer;Kidney Failure, Chronic | AGA |
Canada | (B03XA02) darbepoetin alfa (adm: P) | Aranesp | Liq/Liq. Inj 100 mcg / 0.5 mL,Syringe / seringue | Ex-factory price without vat |
$0-0 |
$0-0 |
Anemia;Cancer;Kidney Failure, Chronic | AGA |
Canada | (B03XA02) darbepoetin alfa (adm: P) | Aranesp | Liq/Liq. Inj 130 mcg / 0.65 mL,Syringe / seringue | Ex-factory price without vat |
$0-0 |
$0-0 |
Anemia;Cancer;Kidney Failure, Chronic | AGA |
Canada | (B03XA02) darbepoetin alfa (adm: P) | Aranesp | Liq/Liq. Inj 150 mcg / 0.3 mL,Syringe / seringue | Ex-factory price without vat |
$0-0 |
$0-0 |
Anemia;Cancer;Kidney Failure, Chronic | AGA |
Canada | (B03XA02) darbepoetin alfa (adm: P) | Aranesp | Liq/Liq. Inj 20 mcg / 0.5 mL,Syringe / seringue | Ex-factory price without vat |
$0-0 |
$0-0 |
Anemia;Cancer;Kidney Failure, Chronic | AGA |
Canada | (B03XA02) darbepoetin alfa (adm: P) | Aranesp | Liq/Liq. Inj 200 mcg / 0.4 mL,Syringe / seringue | Ex-factory price without vat |
$0-0 |
$0-0 |
Anemia;Cancer;Kidney Failure, Chronic | AGA |
Canada | (B03XA02) darbepoetin alfa (adm: P) | Aranesp | Liq/Liq. Inj 30 mcg / 0.3 mL,Syringe / seringue | Ex-factory price without vat |
$0-0 |
$0-0 |
Anemia;Cancer;Kidney Failure, Chronic | AGA |
Canada | (B03XA02) darbepoetin alfa (adm: P) | Aranesp | Liq/Liq. Inj 300 mcg / 0.6 mL,Syringe / seringue | Ex-factory price without vat |
$0-0 |
$0-0 |
Anemia;Cancer;Kidney Failure, Chronic | AGA |
Canada | (B03XA02) darbepoetin alfa (adm: P) | Aranesp | Liq/Liq. Inj 40 mcg / 0.4 mL,Syringe / seringue | Ex-factory price without vat |
$0-0 |
$0-0 |
Anemia;Cancer;Kidney Failure, Chronic | AGA |
Canada | (B03XA02) darbepoetin alfa (adm: P) | Aranesp | Liq/Liq. Inj 50 mcg / 0.5 mL,Syringe / seringue | Ex-factory price without vat |
$0-0 |
$0-0 |
Anemia;Cancer;Kidney Failure, Chronic | AGA |
Canada | (B03XA02) darbepoetin alfa (adm: P) | Aranesp | Liq/Liq. Inj 500 mcg / 1 mL,Syringe / seringue | Ex-factory price without vat |
$0-0 |
$0-0 |
Anemia;Cancer;Kidney Failure, Chronic | AGA |
Canada | (B03XA02) darbepoetin alfa (adm: P) | Aranesp | Liq/Liq. Inj 60 mcg / 0.3 mL,Syringe / seringue | Ex-factory price without vat |
$0-0 |
$0-0 |
Anemia;Cancer;Kidney Failure, Chronic | AGA |
Canada | (B03XA02) darbepoetin alfa (adm: P) | Aranesp | Liq/Liq. Inj 80 mcg / 0.4 mL,Syringe / seringue | Ex-factory price without vat |
$0-0 |
$0-0 |
Anemia;Cancer;Kidney Failure, Chronic | AGA |